These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1409434)

  • 1. A post melanosomal era: control of melanogenesis and melanoma growth.
    Mishima Y
    Pigment Cell Res; 1992; Suppl 2():3-16. PubMed ID: 1409434
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro radiobiological analysis of 10B-L-BPA for BNCT of malignant melanoma: correlation of determined 10B-content and cell killing effect.
    Ichihashi M; Shiono M; Yamamura K; Komura A; Mishima Y; Yoshino K; Hori Y
    Pigment Cell Res; 1992; Suppl 2():193-8. PubMed ID: 1409422
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental boron neutron capture therapy for melanoma: systemic delivery of boron to melanotic and amelanotic melanoma.
    Coderre JA; Glass JD; Packer S; Micca P; Greenberg D
    Pigment Cell Res; 1990 Dec; 3(6):310-8. PubMed ID: 2101931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways mediating melanogenesis.
    Park HY; Gilchrest BA
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):919-30. PubMed ID: 10643996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective affinity of 10B1-paraboronophenylalanine-HCl to malignant melanoma: thermal neutron capture therapy].
    Tsuji M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1983 Jun; 93(7):773-8. PubMed ID: 6620640
    [No Abstract]   [Full Text] [Related]  

  • 6. [RBEs of thermal neutron capture therapy and 10B(n, alpha)7Li reaction on melanoma bearing hamster].
    Hiratsuka J; Kono M; Mishima Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Jun; 48(6):759-66. PubMed ID: 3217252
    [No Abstract]   [Full Text] [Related]  

  • 7. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
    Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature and biological effects of factors responsible for proliferation and differentiation of melanocytes.
    Abdel-Malek ZA; Swope VB; Nordlund JJ
    Pigment Cell Res; 1992; Suppl 2():43-7. PubMed ID: 1329075
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylalanine lowers melanin synthesis in mammalian melanocytes by reducing tyrosine uptake: implications for pigment reduction in phenylketonuria.
    Farishian RA; Whittaker JR
    J Invest Dermatol; 1980 Feb; 74(2):85-9. PubMed ID: 6766172
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormonal regulation of melanogenesis in mouse melanoma and in human melanocytes.
    Fuller BB; Rungta D; Iozumi K; Hoganson GE; Corn TD; Cao VA; Ramadan ST; Owens KC
    Ann N Y Acad Sci; 1993 May; 680():302-19. PubMed ID: 8512220
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of sulfuretin as a depigmenting agent.
    Zhou Z; Hou J; Xiong J; Li M
    Fundam Clin Pharmacol; 2019 Apr; 33(2):208-215. PubMed ID: 30216535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.
    Coderre JA; Slatkin DN; Micca PL; Ciallella JR
    Radiat Res; 1991 Nov; 128(2):177-85. PubMed ID: 1947013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemical compound from fruit extract of Juglans mandshurica inhibits melanogenesis through p-ERK-associated MITF degradation.
    Kim JY; Lee EJ; Ahn Y; Park S; Kim SH; Oh SH
    Phytomedicine; 2019 Apr; 57():57-64. PubMed ID: 30668323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.
    Mishima Y; Ichihashi M; Hatta S; Honda C; Yamamura K; Nakagawa T
    Pigment Cell Res; 1989; 2(4):226-34. PubMed ID: 2678078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered N-glycosylation in macrophage x melanoma fusion hybrids.
    Pawelek JM; Chakraborty AK; Rachkovsky ML; Orlow SJ; Bolognia JL; Sodi SA
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1011-27. PubMed ID: 10644005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of melanogenesis by selina-4(14),7(11)-dien-8-one isolated from Atractylodis Rhizoma Alba.
    Chang YH; Kim C; Jung M; Lim YH; Lee S; Kang S
    Biol Pharm Bull; 2007 Apr; 30(4):719-23. PubMed ID: 17409509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRC-BACR-AICR International Workshop. Melanogenesis: its chemistry as a therapeutic strategy in melanoma.
    Land EJ
    Br J Cancer; 1991 Oct; 64(4):793-5. PubMed ID: 1911230
    [No Abstract]   [Full Text] [Related]  

  • 18. Integumental pigmentary factors of lower vertebrates--models for human hypo- and hypermelanoses.
    Bagnara JT; Fukuzawa T; Johnson WC; Law JH; Samaraweera P; Zuasti A
    Pigment Cell Res; 1992; Suppl 2():254-61. PubMed ID: 1409427
    [No Abstract]   [Full Text] [Related]  

  • 19. Local control of subcutaneous murine melanoma xenografts in nude mice by neutron capture therapy.
    Allen BJ; Corderoy-Buck S; Mallesch JL; Crotty K; Moore DE
    Melanoma Res; 1992 Nov; 2(4):253-62. PubMed ID: 1490113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
    Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.